EnilloRing (Etonogestrel & Ethinyl Estradiol Vaginal Ring)

Pharmacies, wholesalers, and distributors that stock hormonal contraceptives need a product they can dispense with confidence and reorder without disruption. EnilloRing from Xiromed answers that need. This combined hormonal contraceptive vaginal ring pairs Etonogestrel with Ethinyl Estradiol in a single flexible ring, giving your inventory a dependable, non-oral option backed by consistent manufacturing and clearly documented specifications.

Product Overview

EnilloRing is a combined hormonal contraceptive vaginal ring supplied at a strength of 120 mcg / 15 mcg. Each carton holds three individually pouched rings in a 1 x 3 pack, so patients receive a supply that spans multiple cycles without an early refill. That configuration keeps reorder rhythms predictable and helps pharmacy teams manage stock without excess handling.

Unlike a daily oral tablet, EnilloRing is a self-administered ring worn intravaginally, then removed on schedule per the approved labeling. This non-oral delivery gives prescribers a practical alternative for patients who prefer a monthly-cycle method over a daily pill, adding useful breadth to your contraceptive category.

EnilloRing carries NDC 70700-156-91, so buyers can verify the exact configuration before placing an order and match it accurately against inventory systems. Each ring delivers a fixed, standardized daily amount of both hormones, which removes guesswork and helps dispensers work with precision.

For distributors building out a women’s health or contraceptive category, EnilloRing slots in cleanly. It fills a recognized therapeutic need, ships in a familiar pack size, and arrives with the documentation your compliance and procurement teams expect from a reliable supplier.

Active Ingredients and Their Roles

The value of any combined hormonal contraceptive lies in how its two hormones work together. EnilloRing brings together two well-known agents, each with a defined purpose within the ring.

Etonogestrel (120 mcg/day) is the progestin component. Etonogestrel is a widely used progestin in contraceptive practice, and its inclusion supports the core contraceptive effect of the ring. Delivered steadily through the vaginal route, it releases at a controlled daily rate rather than in a single oral dose.

Ethinyl Estradiol (15 mcg/day) is the estrogen component. In a combined hormonal contraceptive, the estrogen works alongside the progestin to support cycle regulation and contribute to the overall contraceptive effect. The 15 mcg daily release reflects a low-dose estrogen level, aligning EnilloRing with familiar prescribing patterns.

By releasing both hormones from one flexible ring, EnilloRing keeps the regimen simple. Patients manage a single product on a monthly cycle rather than a daily tablet, and dispensers handle one SKU. That simplicity supports adherence and streamlines day-to-day pharmacy operations.

Indications and Use

EnilloRing belongs to the combined hormonal contraceptive category and is intended for use under the direction of a qualified healthcare professional. Products of this type are commonly prescribed for the prevention of pregnancy in patients who choose to use a vaginal ring contraceptive.

Prescribing decisions, dosing, insertion and removal schedules, patient selection, screening, and treatment duration should always follow the approved product labeling and the clinical judgment of the treating physician. This description is written for licensed professionals and authorized trade partners and is not a substitute for the full prescribing information. Always confirm indications, contraindications, and directions against the current labeling before dispensing.

Pack Configuration and Key Details

Clear specifications reduce ordering errors and keep procurement moving. Confirm the following before adding EnilloRing to your catalog:

Detail	Specification
Product name	EnilloRing (Etonogestrel & Ethinyl Estradiol Vaginal Ring)
Active ingredients	Etonogestrel / Ethinyl Estradiol
Strength	120 mcg / 15 mcg (per day)
Pack size	1 x 3 pack (3 rings)
NDC	70700-156-91
Dosage form	Vaginal ring
Route of administration	Intravaginal
Category	Combined hormonal contraceptive
Supplier	Xiromed

The three-ring pack supports consecutive cycles, so patients move through treatment without an early refill. For pharmacy operations, that means fewer partial-supply issues and a cleaner, more predictable reorder pattern.

Why Source Through Xiromed

Reliable supply matters as much as the product itself. Xiromed manufactures its portfolio to meet stringent regulatory standards, and EnilloRing holds to the same benchmark. Each batch is produced with consistency in mind, so your supply chain receives a product that performs the same way order after order.

Sourcing EnilloRing directly through Xiromed gives buyers verified specifications, a confirmed NDC for accurate matching, and a supply relationship built around the demands of pharmacies and distributors. When availability and documentation both matter, working with a manufacturer that prioritizes each makes procurement simpler.

If you are expanding your contraceptive offering or securing a steady source for an existing line, EnilloRing is a straightforward addition. To order or request further product information, connect with the Xiromed team and reference NDC 70700-156-91 to confirm the exact 120 mcg / 15 mcg, 1 x 3 pack configuration for your inventory.

---

This information is intended for licensed healthcare professionals, pharmacies, and authorized distributors. EnilloRing is a prescription product and should be used only as directed by a qualified healthcare provider in accordance with the approved product labeling. Product availability, specifications, and regulatory status may vary by region. Refer to the full prescribing information before dispensing.